APOB and type 2 diabetes mellitus: By identifying Apo-B and triglycerides as key predictors of T2DM and clarifying the role of Lp(a) in metabolic risk stratification, our findings can inform clinical decision-making and guide future research aimed at improving both cardiovascular and metabolic outcomes.